Dr. Al-Hertani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1201 W La Veta Ave
Orange, CA 92868Phone+1 714-509-4873Fax+1 714-509-4788
Summary
- Incoming Division Chief of the Metabolic Disorders Division at CHOC. Previously Harvey Levy Endowed Chair in Metabolism and the Director of the Metabolism, Lysosomal and Glycogen Storage Disease programs at Boston Children's Hospital. MD degree from Dalhousie University; Medical Genetics Residency at University of Ottawa/CHEO; Biochemical Genetics Fellowship at University of Toronto/SickKids.
Education & Training
- University of Toronto/Hospital for Sick Children (SickKids)FCCMG, Biochemical Genetics, 2010 - 2012
- University of Ottawa/Children’s Hospital of Eastern Ontario (CHEO)FRCPC, FCCMG, Medical Genetics, 2005 - 2010
- Dalhousie University Faculty of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2024 - 2026
- MA State Medical License 2019 - 2025
- NC State Medical License 2020 - 2022
- ME State Medical License 2020 - 2021
- RI State Medical License 2020 - 2020
Awards, Honors, & Recognition
- Postgraduate Mentorship Award Cummings School of Medicine/University of Calgary, 2019
- Postgraduate Teaching Award McGill University, 2014
- Humanitarian Award Hospital for Sick Children/SickKids/SickKids Foundation, 2011
- Join now to see all
Clinical Trials
- Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia Start of enrollment: 2021 Apr 15
Roles: Principal Investigator
- Early Access Program With Arimoclomol in US Patients With NPC
Roles: Contact
Publications & Presentations
PubMed
- Implications of the choroid plexus in Niemann-Pick disease Type C neuropathogenesis.Raquel van Gool, Mariesa Cay, Boyu Ren, Kailey Brodeur, Emma Golden
Brain, Behavior, and Immunity. 2024-12-15 - Intravenous Idursulfase for the Treatment of Mucopolysaccharidosis Type II: A Systematic Literature Review.Walla Al-Hertani, Ravi R Pathak, Obaro Evuarherhe, Gemma Carter, Carolyn R Schaeffer-Koziol
International Journal of Molecular Sciences. 2024-08-06 - Monitoring and integrated care coordination of patients with alpha-mannosidosis: A global Delphi consensus study.Nathalie Guffon, Barbara K Burton, Can Ficicioglu, Martin Magner, Mercedes Gil-Campos
Molecular Genetics and Metabolism. 2024-08-01
Press Mentions
- Gene Therapy May Reverse Hurler Syndrome, a Rare and Severe Illness in KidsNovember 18th, 2021
External Links
- LinkedInhttp://www.linkedin.com/in/hertanw
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: